Opna Bio establishes CDD Vault as central repository for preclinical data

In this case study, Collaborative Drug Discovery highlights Opna Bio's utilization of the CDD Vault^® Registration System and ELN as the central repository for its extensive preclinical data. Opna Bio, founded in 2019 in Lausanne, Switzerland, concentrates on discovering and developing small molecule oncology therapeutics. Its portfolio encompasses early discovery to mid-clinical stage small molecule drug programs specifically designed to target cancer hallmarks.